Bocouture 100 IU

Bocouture® 100 IU is a prescription injectable medication containing 100 International Units (IU) of botulinum neurotoxin type A (incobotulinumtoxinA). It is used in aesthetic medicine to temporarily improve the appearance of dynamic facial wrinkles caused by repeated muscle movements. In some markets, the same active ingredient is also used for therapeutic indications under a different brand name. Bocouture should only be administered by qualified healthcare professionals with appropriate training in facial anatomy and injection techniques. The active ingredient is: Bocouture Bocouture 100 IU is supplied as a sterile, freeze-dried (lyophilized) powder in a single-use vial. Before administration, it is reconstituted with sterile saline according to the manufacturer’s instructions. Unlike some other botulinum toxin formulations, Bocouture contains a highly purified neurotoxin with no complexing proteins, which may be a consideration in certain clinical situations.

Composition

Each vial typically contains:

• 100 International Units (IU) of incobotulinumtoxinA
• Human albumin
• Sucrose

The formulation is preservative-free and intended for single-patient use after reconstitution.

Storage Requirements

To preserve product quality:

• Store according to the manufacturer’s labeling.
• Protect from excessive heat and direct sunlight.
• Reconstitute only with sterile saline.
• Use the reconstituted solution within the recommended timeframe.
• Maintain sterile handling procedures.

Safety Information

Bocouture is a prescription medication and should only be administered by qualified healthcare professionals.

It may not be appropriate for individuals with certain neuromuscular disorders, active infections at the injection site, or known allergies to any component of the formulation. Patients who are pregnant, breastfeeding, or have other significant medical conditions should consult a healthcare provider before treatment.

Possible side effects include:

• Injection-site pain or bruising
• Headache
• Temporary eyelid drooping
• Localized muscle weakness
• Swelling or redness at the injection site

Serious adverse reactions are uncommon but require prompt medical attention.

Mechanism of Action

Bocouture works by temporarily blocking the release of acetylcholine at the neuromuscular junction, reducing the activity of targeted muscles.

This results in:

• Temporary muscle relaxation
• Softening of dynamic facial lines
• Reduction of muscle contractions in treated areas

Product Features

• 100 IU potency per vial
• Contains highly purified incobotulinumtoxinA
• Free from complexing proteins
• Sterile lyophilized powder
• Precise dosing by trained healthcare professionals
• Suitable for approved aesthetic applications
• Refrigerated storage may be required according to local product labeling

1. Minimally Invasive

Provides wrinkle reduction without surgery.

2. Highly Purified Formulation

Contains incobotulinumtoxinA without complexing proteins.

3. Fast Treatment

Most injection sessions take only a few minutes.

4. Temporary Results

Effects gradually wear off, allowing treatment adjustments over time.

5. Clinically Established

Widely used by trained medical professionals for approved indications.

Common Cosmetic Uses

Depending on local regulatory approvals, Bocouture may be used to temporarily improve the appearance of:

• Glabellar (frown) lines between the eyebrows
• Horizontal forehead lines
• Crow’s feet around the eyes
• Other dynamic facial wrinkles as determined by a qualified healthcare professional

Therapeutic Uses

In some countries, therapeutic indications for incobotulinumtoxinA are marketed under a different brand name and may include:

• Cervical dystonia
• Blepharospasm
• Limb spasticity
• Other approved neurological conditions

Approved indications vary by country and regulatory authority.

Typical Duration of Effect

Treatment results vary depending on the indication and individual response. Cosmetic effects typically begin within 2–4 days, become fully apparent within about 2 weeks, and generally last 3–4 months before muscle activity gradually returns.